Curcumin and COVID-19 Studies
Many of you already know about curcumin’s impressive anti-inflammatory properties. Now new research is showing that curcumin may provide a meaningful contribution in lowering the severity and death rates of Covid-19. In his article Curcumin and COVID-19 Studies, Dr. Joseph Mercola provides an excellent overview of how curcumin might improve your health, reduce pain from inflammation, and even minimize the severity of Covid-19. The curcumin-based supplement Curcugen appears to have even better bioavailability than standard curcumin.
Dr. Mercola summarizes:
- Curcumin, the major biologically active phenolic compound in turmeric, ranks in the top five out of 25 compounds for effectiveness in lowering severity of COVID-19 and death rates from COVID
- The top drug, proxalutamide, is an androgen antagonist that limits the expression of transmembrane protein serine 2 (TMPRSS2), a receptor the virus uses to infect cells. One study found curcumin could also decrease expression up to 50%
- Curcumin has poor absorption and rapid metabolism and elimination. It must be combined with another compound to improve bioavailability, such as piperine found in black pepper; a recently tested supplement, CURCUGEN, was found to have better bioavailability than the standard reference product
- Evidence shows curcumin also reduces pain and inflammation in those with arthritis, may improve cognitive function, and could help reduce chronic inflammation associated with cardiovascular disease, obesity and insulin resistance
Analysis by Dr. Joseph Mercola